transparent gif

 

Ej inloggad.

Göteborgs universitets publikationer

Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease

Författare och institution:
W. Tajeddinn (-); T. Persson (-); J. Calvo-Garrido (-); M. S. Ahmed (-); S. Maioli (-); S. Vijayaraghavan (-); M. S. Kazokoglu (-); C. Parrado-Fernandez (-); T. Yoshitake (-); J. Kehr (-); P. Francis (-); B. Winblad (-); Kina Höglund (Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi); A. Cedazo-Minguez (-); D. Aarsland (-)
Publicerad i:
Journal of Alzheimers Disease, 53 ( 1 ) s. 349-361
ISSN:
1387-2877
Publikationstyp:
Artikel, refereegranskad vetenskaplig
Publiceringsår:
2016
Språk:
engelska
Fulltextlänk:
Sammanfattning (abstract):
Serotonin (5-HT) plays a central role in the integrity of different brain functions. The 5-HT homeostasis is regulated by many factors, including serotonin transporter (SERT), monoamine oxidase enzyme (MAO), and several 5-HT receptors, including the 5-HT1B. There is little knowledge how the dynamics of this system is affected by the amyloid-beta (A beta) burden of Alzheimer's disease (AD) pathology. SH-SY5Y neuroblastoma cells transfected with the amyloid precursor protein (APP) gene containing the Swedish mutations causing familial AD (APPswe), were used as a model to explore the effect of A beta pathology on 5-HT1B and related molecules including the receptor adaptor protein (p11), SERT and MAOA gene expression, and MAOA activity after treatment with selective serotonin reuptake inhibitor (SSRI) (sertraline), and a 5-HT1B receptor antagonist. Sertraline led more than 70 fold increase of 5-HT1B gene expression (p < 0.001), an increased serotonin turnover in both APPswe and control cells and reduced intracellular serotonin levels by 75% in APPswe cells but not in controls (p > 0.05). Treatment with the 5-HT1B receptor antagonist increased SERT gene-expression in control cells but not in the APPswe cells. 5-HT and 5-HT1B antagonist treatment resulted in different p11 expression patterns in APPswe cells compared to controls. Although MAOA gene expression was not changed by APPswe overexpression, adding 5-HT lead to a significant increase in MAOA gene expression in APPswe but not control cells. These findings suggest that the sensitivity of the 5-HT1B receptor and related systems is affected by APPswe overexpression, with potential relevance for pharmacologic intervention in AD. This may at least partly explain the lack of effect of SSRIs in patients with AD and depression.
Ämne (baseras på Högskoleverkets indelning av forskningsämnen):
MEDICIN OCH HÄLSOVETENSKAP ->
Medicinska grundvetenskaper ->
Neurovetenskaper
Nyckelord:
5-HT1B receptor, Alzheimer's disease, APPswe, MAOA, p11, serotonin, SERT, 5-ht1b receptor, cerebrospinal-fluid, cognitive symptoms, messenger-rna, in-vitro, depression, activation, dementia, mice, rat, Neurosciences & Neurology
Postens nummer:
240233
Posten skapad:
2016-08-15 11:31
Posten ändrad:
2016-08-15 11:32

Visa i Endnote-format

Göteborgs universitet • Tel. 031-786 0000
© Göteborgs universitet 2007